19/05/2022
Circulating vaccine-derived poliovirus, nOPV2, Outbreak countries
Afghanistan, Africa, India, Pakistan
Coffee With Polio Experts: Dr Ananda Bandyopadhyay
Ananda talks about development of the nOPV2 vaccine its pathway to rollout, and field performance
In this two-part video series, we chat with Dr Ananda Bandyopadhyay, Deputy Director of Polio Technology, Research & Analytics, BMGF, about the new tool in GPEI’s kit to combat cVDPV2: novel oral polio vaccine type 2 (nOPV2).
Related News
30/03/2023
An interview with co-leads of GPEI’s nOPV Working Group on nOPV2 field use to date
Notice: Undefined variable: default_image in /var/www/vhosts/polioeradication.org/httpdocs/wp-content/themes/gpei/single-news.php on line 121
16/03/2023
16 March 2023
10/03/2023
On Tuesday 28 February 2023, ministers and high-level delegates from across the Eastern Mediterranean Region participated in the seventh meeting of the Regional Subcommittee for Polio Eradication and Outbreaks.
06/03/2023
Seventh meeting of the Regional Subcommittee for Polio Eradication and Outbreaks - 28 February 2023
23/02/2023
Senior representatives from the Global Polio Eradication Initiative (GPEI) today commended the Government of Mozambique for its ongoing polio response efforts to ensure that every child is protected from the devastating impacts of the virus.
17/02/2023
A year since Malawi confirmed its first case of WPV1 in 30 years, more than 33 million children across five southern African countries have been vaccinated against the virus, with over 80 million vaccine doses administered over the past year
